Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 310.5469
- Book/Share 57.6123
- PB 1.3983
- Debt/Equity 1.121
- CurrentRatio 0.8319
- ROIC 0.0043
- MktCap 102011594495.0
- FreeCF/Share 4.959
- PFCF 16.2103
- PE 217.4346
- Debt/Assets 0.3202
- DivYield 0.0331
- ROE 0.0062
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | CVS | Goldman | -- | Buy | -- | $91 | Oct. 14, 2025 |
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
Why Is CVS Health (CVS) Up 4.1% Since Last Earnings Report?
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Read More
CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?
Published: November 25, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.
Read More
Curaechoice Selects CVS Caremark at its PBM
Published: November 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1
Read More
CVS Aetna's New Generative AI Assistant Aims to Simplify Health Care
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health's Aetna debuts an embedded generative AI assistant designed to simplify benefits navigation and elevate the consumer health experience.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Published: November 19, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
Aetna Launches Leading Edge Conversational AI Navigation
Published: November 18, 2025 by: PRNewsWire
Sentiment: Neutral
Embedded assistant revolutionizes how members navigate their health care journey WOONSOCKET, R.I. , Nov. 18, 2025 /PRNewswire/ -- Aetna, a CVS Health® company (NYSE: CVS), is launching a market-leading generative AI-powered conversational experience in its digital channels that will simplify health care, allowing members to quickly and easily navigate their benefits for a personalized experience.
Read More
CVS edges higher as vet group flags steady growth and Australian deal-making
Published: November 18, 2025 by: Proactive Investors
Sentiment: Positive
Shares in CVS Group (AIM:CVSG) nudged less than 1% higher after the veterinary services company said trading was in line with expectations, with early-year momentum holding up despite a tougher backdrop in the UK. At its annual meeting, the group reported sales up 5.7% in the four months to the end of October and a 6.2% rise in adjusted earnings.
Read More
Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Systems on CVS Caremark Commercial Template Formularies
Published: November 06, 2025 by: Business Wire
Sentiment: Neutral
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)-- #TRUEMETRIX--Trividia Health, Inc., announced today that it's TRUE METRIX® Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the United States, replacing OneTouch® branded blood glucose monitors and test strips. The TRUE METRIX® portfolio delivers scientifically backed performance built on decades of research and technological innovation. The TRUE METRIX meters and test strips feature TRIP.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: November 05, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
CVS Health Boosts CVS Pharmacy Customer Generosity to Address Food Insecurity
Published: October 31, 2025 by: PRNewsWire
Sentiment: Neutral
WOONSOCKET, R.I. , Oct. 31, 2025 /PRNewswire/ -- CVS Pharmacy® customers donated more than $3 million this year to support local food banks across the country, and CVS Health® (NYSE: CVS) is boosting the overall contribution to support Feeding America.
Read More
My Top 10 High-Yield Picks For November 2025: One Yields 9%+
Published: October 30, 2025 by: Seeking Alpha
Sentiment: Positive
I present a diversified selection of high-yield dividend stocks with strong income and growth potential, including CVX, VZ, MO, ARCC, and others. Each company was selected for sustainable dividends, attractive yields, reasonable payout ratios, and a proven record or potential for dividend growth. CVX and ARCC receive positive Wall Street ratings, while VZ and MO offer high yields and strong free cash flow, supporting portfolio income stability.
Read More
CVS Posts Loss on Write-Down, Boosts Guidance
Published: October 29, 2025 by: WSJ
Sentiment: Neutral
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
Read More
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates
Published: October 29, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.09 per share a year ago.
Read More
CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings
Published: October 29, 2025 by: Market Watch
Sentiment: Negative
CVS Health's stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report.
Read More
CVS Posts Loss on Write-Down, Boosts Guidance
Published: October 29, 2025 by: WSJ
Sentiment: Neutral
CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.
Read More
CVS Reports Big Loss On Devalued Oak Street Clinics But Aetna Costs Are Stable
Published: October 29, 2025 by: Forbes
Sentiment: Negative
CVS Health Wednesday reported a $4 billion third-quarter loss related to the reduced value of its Oak Street Health primary care facilities, but the company is getting a handle on health costs that have hit its Aetna health insurance business.
Read More
CVS raises full-year forecast, takes $5.7 billion impairment charge on health clinics
Published: October 29, 2025 by: Reuters
Sentiment: Neutral
CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy MinuteClinics.
Read More
CVS beats estimates, hikes guidance as insurance business improves
Published: October 29, 2025 by: CNBC
Sentiment: Positive
CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap David Joyner's first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under Karen Lynch.
Read More
CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE
Published: October 29, 2025 by: PRNewsWire
Sentiment: Neutral
Financial Highlights Third quarter total revenues increased to a record high $102.9 billion, up 7.8% compared to prior year Third quarter GAAP diluted loss per share of $3.13, inclusive of a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit Third quarter Adjusted EPS of $1.60 Generated year-to-date cash flow from operations of $7.2 billion Operational Highlights Aetna® receives industry-leading Medicare Advantage Star Ratings results Launch of annual vaccination campaign at CVS Pharmacy® and MinuteClinic® locations nationwide Caremark® closes out another strong selling season with contract wins totaling nearly $6.0 billion and retention in the high …
Read More
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?
Published: October 28, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.
Read More
CVS Health: Slow And Steady Wins The Healthcare Race
Published: October 27, 2025 by: Seeking Alpha
Sentiment: Positive
CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and continued double-digit growth in health services and pharmacy segments. CVS stock trades at a significant valuation discount to sector and market averages, despite steady top-line growth and a 3.25% dividend yield.
Read More
CVS To Close 16 Oak Street Health Centers Amid Industry Cost Issues
Published: October 24, 2025 by: Forbes
Sentiment: Negative
CVS Health is shuttering 16 Oak Street Health Centers, or 7% of the total number of the senior-focused primary care locations the company operates across the U.S.
Read More
CVS Stock: $31 Bil Shareholder Returns
Published: October 24, 2025 by: Forbes
Sentiment: Positive
Over the past ten years, CVS Health stock (NYSE: CVS) has returned $31 billion to shareholders in the form of cash through dividends and buybacks. This shareholder-focused strategy has delivered exceptional results in 2025, with the stock posting a remarkable 81% year-to-date return, representing one of the most dramatic healthcare sector turnarounds after suffering a 42% decline in 2024 and demonstrating the company's successful navigation through post-pandemic challenges.
Read More
Countdown to CVS Health (CVS) Q3 Earnings: Wall Street Forecasts for Key Metrics
Published: October 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Read More
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
CVS Health (CVS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Published: October 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000